EMA To Focus On Filings For Novel Drugs Under Restart Of Trial Transparency Policy

 
• By Vibha Sharma

The European Medicines Agency is working on restarting its landmark policy on publishing clinical trial data, with the first phase expected to start this year.

We all say yes! Close up shot of four young people workers clients of different gender ethnicity raising thumbs up showing general support acceptance recognition to company policy, service or product
Publishing clinical trial data can improve public trust in regulatory decisions • Source: Shutterstock

More from Europe

More from Geography